- Home
- STSS vs AZTR Comparison
STSS vs AZTR Comparison
Compare STSS & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STSS
- AZTR
- Stock Information
- Founded
- STSS 2017
- AZTR 2014
- Country
- STSS United States
- AZTR United States
- Employees
- STSS N/A
- AZTR N/A
- Industry
- STSS Medical/Dental Instruments
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- STSS Health Care
- AZTR Health Care
- Exchange
- STSS Nasdaq
- AZTR Nasdaq
- Market Cap
- STSS 4.6M
- AZTR 5.2M
- IPO Year
- STSS 2022
- AZTR 2023
- Fundamental
- Price
- STSS $5.87
- AZTR $0.28
- Analyst Decision
- STSS
- AZTR
- Analyst Count
- STSS 0
- AZTR 0
- Target Price
- STSS N/A
- AZTR N/A
- AVG Volume (30 Days)
- STSS 2.6M
- AZTR 806.0K
- Earning Date
- STSS 05-15-2025
- AZTR 05-13-2025
- Dividend Yield
- STSS N/A
- AZTR N/A
- EPS Growth
- STSS N/A
- AZTR N/A
- EPS
- STSS N/A
- AZTR N/A
- Revenue
- STSS N/A
- AZTR $7,500.00
- Revenue This Year
- STSS N/A
- AZTR N/A
- Revenue Next Year
- STSS N/A
- AZTR N/A
- P/E Ratio
- STSS N/A
- AZTR N/A
- Revenue Growth
- STSS N/A
- AZTR N/A
- 52 Week Low
- STSS $3.36
- AZTR $0.23
- 52 Week High
- STSS $2,904.00
- AZTR $12.00
- Technical
- Relative Strength Index (RSI)
- STSS 42.25
- AZTR 44.09
- Support Level
- STSS $3.44
- AZTR $0.27
- Resistance Level
- STSS $7.04
- AZTR $0.29
- Average True Range (ATR)
- STSS 0.51
- AZTR 0.02
- MACD
- STSS 1.33
- AZTR -0.00
- Stochastic Oscillator
- STSS 67.47
- AZTR 30.20
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.